Cleveland Eye Clinic
The goal of this study is to evaluate whether TearCare treatment stabilizes corneal measurements sufficiently to determine when cataract biometry can be considered reliable.
Dry eye disease (DED), particularly meibomian gland dysfunction (MGD)-driven DED, is highly prevalent in the cataract-age population and significantly impacts the accuracy and repeatability of pre-operative corneal measurements. Instability of the tear film may result in variability in keratometry, corneal topography, higher order aberrations (HOA), and intraocular lens (IOL) power calculations. The TearCare System is an in-oAice therapeutic system designed to treat MGD through localized thermal eyelid therapy followed by gland expression cleared. Improving tear film stability may enhance cor…
Inclusion Criteria: 1. Age 50-75 years 2. Diagnosis of MGD and DED 3. OSDI score 23-79 4. TBUT \> 1 second and ≤ 7 seconds 5. MGSS \<12 in both eyes 6. ≥15 expressible meibomian glands 7. Candidate for cataract surgery planning (ie. Phakic) Exclusion Criteria: 1. Use of: 1. Cyclosporine, Xiidra, or serum tears within 30 days prior to Screening; 2. Antihistamines (oral or topical) within 7 days prior to Screening; 3. Oral tetracyclines or azithromycin within 30 days prior to Screening; 4. Topical ophthalmic antibiotics, anti-glaucoma medications, steroids, nonsteroidal anti-infl…
In this study the TearCare procedure and system is being used to provide thermal eyelid therapy before manual expression by the PI.
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.